Thrive Earlier Detection Stock

thrivedetect.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $110MM

Thrive is the developer a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages.

Register To Buy and Sell Shares

For more details on financing and valuation for Thrive Earlier Detection, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Thrive Earlier Detection’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Thrive Earlier Detection.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Kenneth Kinzler Ph.D
Co-Founder & Board Member
Christoph Lengauer Ph.D
Co-Founder, Board Member & Chief Innovation Officer
Isaac Ro
Chief Financial Officer
Bert Vogelstein MD
Co-Founder
Samantha Singer
Chief Operating Officer
Steven Kafka Ph.D
Executive Chairman

Board Members

Christoph Lengauer Ph.D
Steven Kafka Ph.D
Kenneth Kinzler Ph.D
Alexis Borisy
Third Rock Ventures
Michael Pellini MD
Section 32

Frequently Asked Questions About Thrive Earlier Detection’s Stock

plusminus
Can you buy Thrive Earlier Detection’s stock?
Thrive Earlier Detection is not publicly traded on NYSE or NASDAQ in the U.S. To buy Thrive Earlier Detection’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Thrive Earlier Detection’s stock?
Yes, you can sell stock of a private company like Thrive Earlier Detection. Forge can help you sell your Thrive Earlier Detection stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Thrive Earlier Detection’s stock price?
Thrive Earlier Detection is a privately held company and therefore does not have a public stock price. However, you may access Thrive Earlier Detection’s private market stock price with Forge Data.
plusminus
What is Thrive Earlier Detection’s stock ticker symbol?
Thrive Earlier Detection does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Thrive Earlier Detection Raises $257M in Series B Financing | FinSMEs
Thrive Earlier Detection Corp., a Cambridge, MA-based company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, raised $257m in Series B financing
Thrive Earlier Detection Announces Appointment of Seema Singh Bhan as Senior Vice President, Public Policy and External Affairs
Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care,
Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer
Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care,
Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.